Loading...
TO THE Concern Person — Ibrutinib Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #8 buyer for Ibrutinib · $15.1K import value · 5 shipments · BRAZIL · DGFT Verified
TO THE Concern Person is the #8 importer of Ibrutinib from India with $15.1K in import value and 5 verified shipments. TO THE Concern Person holds a 1.5% market share in Ibrutinib imports based in BRAZIL. Overall, TO THE Concern Person imports 4 pharmaceutical products worth $269.2K across 2 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NIVIRA EXPORTS | $239.9K | 60 | 2 |
| VAMA LIFECARE PRIVATE LIMITED | $203.2K | 60 | 1 |
| RBN MEDITECH PRIVATE LIMITED | $41.7K | 6 | 1 |
| SHREE KRISHNA LIFECARE | $32.7K | 16 | 1 |
| MEDIGEN PHARMA | $29.7K | 3 | 2 |
| RMPL PHARMA LLP | $29.2K | 25 | 3 |
| RAVI PHARMA | $25.3K | 5 | 1 |
| JPC GLOBAL | $20.9K | 23 | 3 |
| KALINDI OVERSEAS | $20.6K | 19 | 2 |
| ROYAL MEDICAL PRIVATE LIMITED | $17.6K | 14 | 1 |
India's top Ibrutinib suppliers include NIVIRA EXPORTS, VAMA LIFECARE PRIVATE LIMITED, RBN MEDITECH PRIVATE LIMITED. These companies represent the primary source of Ibrutinib exports from India, serving buyers like TO THE Concern Person in BRAZIL and other global markets.
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | INVOICE RAISED TO | UNITED ARAB EMIRATES | $29.5K | 5 | $5.9K |
| 7 | DIRCE CANDIDA DA SILVA | BRAZIL | $17.7K | 3 | $5.9K |
| 8 | TO THE CONCERN PERSON ★ | BRAZIL | $15.1K | 5 | $3.0K |
| 9 | JACINTO FERREIRA DA SILVA | BRAZIL | $11.3K | 2 | $5.7K |
What TO THE Concern Person and other importers must comply with to import Ibrutinib from India
Brazilian Health Regulatory Agency (ANVISA)
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
India exported $477.3K worth of Ibrutinib through 560 shipments from 103 suppliers to 60 countries, serving 210 buyers globally. TO THE Concern Person imports $15.1K of this total, accounting for 1.5% of India's Ibrutinib exports with 5 shipments from BRAZIL.
TO THE Concern Person's average Ibrutinib order value is $3.0K per consignment, based on 5 shipments totaling $15.1K. TO THE Concern Person is based in BRAZIL and ranks #8 among all Ibrutinib importers from India by value.
Top Indian Ibrutinib suppliers include NIVIRA EXPORTS ($239.9K), VAMA LIFECARE PRIVATE LIMITED ($203.2K), RBN MEDITECH PRIVATE LIMITED ($41.7K), SHREE KRISHNA LIFECARE ($32.7K), MEDIGEN PHARMA ($29.7K). These companies represent the primary source of Ibrutinib exports from India.
TO THE Concern Person ranks #8 among 210 Ibrutinib importers from India with a 1.5% market share. The top 3 importers are TO THE, ($142.8K), VALTER LUIZ CACHELLI ($70.8K), ACI LOGISTICS DWC LLC ($55.8K). TO THE Concern Person processed 5 shipments from BRAZIL.
TO THE Concern Person also imports these advanced oncology products. Each links to the detailed product page.
TO THE Concern Person imports 4 products worth $269.2K. Beyond Ibrutinib, top products include Osimertinib, Daratumumab, Ustekinumab. View the complete TO THE Concern Person profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ibrutinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for TO THE Concern Person's Ibrutinib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TO THE Concern Person
Full Company Profile →
4 products · $269.2K total trade · 2 categories
| 10 |
| MANOEL JOAQUIM DA SILVA |
| BRAZIL |
| $9.8K |
| 3 |
| $3.3K |
TO THE Concern Person ranks #8 among 210 Ibrutinib importers from India. Average shipment value of $3.0K compared to the market average of $2.3K. The closest competitors by value are INVOICE RAISED TO and DIRCE CANDIDA DA SILVA.
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 60+ countries, 210+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for TO THE Concern Person.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ibrutinib. For current order-level data, contact TransData Nexus.